Central Venous Catheter Market to Surpass US$ 1.9 Billion by 2026 - Coherent Market Insights

Global Central Venous Catheter Market, by Product Type (Peripherally Inserted Central Catheters, Implantable Port, Tunneled Central Venous Catheter, and Non-tunneled Central Venous Catheter), by Design (Single Lumen, Double Lumen, and Multiple Lumen), by Composition (Polyurethane, Polyethylene, and Silicon), by Procedure (Cardiovascular Procedure, Chemotherapy Procedure, and Dialysis Procedure), by End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 1,167.4 million in 2017, and is projected to exhibit a CAGR of 6.2% over the forecast period (2018 – 2026), as highlighted in a new report published by Coherent Market Insights.

Launch of novel catheter systems by market players to augment the market growth

Key players in the market are focused on launching novel catheters in order to reduce thrombus accumulation and address the critical unmet needs of patients in venous access. For instance, in February 2018, Access Vascular received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for HydroPICC, a peripherally inserted central catheter, intended for long-term use. The catheter demonstrated a 30x reduction in platelet count in the pre-clinical testing.

Similarly, in August, 2017, Bactiguard's central venous catheter received regulatory approval in India by Ministry of Health & Family Welfare, thereby providing new opportunities for Bactiguard in offering effective infection prevention among the fastest growing markets in the world. In 2016, Bluegrass Vascular Technologies received CE Mark approval for Surfacer Inside-Out Access Catheter System that is used for obtaining central venous access to facilitate catheter insertion into the central venous system via a novel Inside-Out approach. The innovative approach preserves right-sided venous access despite chronic occlusion and retains the viability of other existing central veins.

Browse 38 Market Data Tables and 32 Figures spread through 174 Pages and in-depth TOC on ‘Central Venous Catheter Market’- Global Forecast to 2026, by Product Type (Peripherally Inserted Central Catheters, Implantable Port, Tunneled Central Venous Catheter, and Non-tunneled Central Venous Catheter), by Design (Single Lumen, Double Lumen, and Multiple Lumen), by Composition (Polyurethane, Polyethylene, and Silicon), by Procedure (Cardiovascular Procedure, Chemotherapy Procedure, and Dialysis Procedure), by End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the central venous catheter market, click the link below:

https://www.coherentmarketinsights.com/market-insight/central-venous-catheter-market-2400

Key players in the market are focused on adopting strategies such as mergers and acquisitions to enhance their product portfolio. For instance, in July 2018, Becton, Dickinson and Company acquired TVA Medical, Inc., a company involved in developing minimally-invasive vascular access solutions for patients with chronic kidney disease requiring hemodialysis.

Key Takeaways of the Central Venous Catheter Market:

• The global central venous catheter market is expected to exhibit a CAGR of 6.2% over the forecast period, owing to the increasing prevalence of cardiopulmonary conditions, cancer and renal diseases.
• Among product type, the peripherally inserted central catheter segment held a dominant position in the central venous catheter market in 2018, owing to higher adoption of catheters for a variety of treatment options such as antibiotic treatment, nutrition, and chemotherapy
• Among design type, multi lumen segment held a dominant position in the central venous catheter market in 2018, as multiple lumen facilitates administration of more than 1 treatment at once
• Among composition, polyurethane segment held a dominant position in the central venous catheter market in 2018, as polyurethane offers greater compatibility, good flexibility, thereby decreasing the breakage and offering high safety to patients
• Among procedure type, chemotherapy procedure segment held a dominant position in the central venous catheter market in 2018, as catheters are efficient alternatives to conventional drug infusion techniques for chemotherapy. Increasing incidence of cancer also contributes to growth of the segment.
• Key players operating in the global central venous catheter market include, AngioDynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and Theragenics Corporation

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, 
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]